The important role of fungi in inflammatory bowel diseases

References

• Sartor RB, Wu GD. Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches. Gastroenterology. 2017;152(2):327–339.e4.
   PubMed Web of Science ®Google Scholar
• Qiu X, Ma J, Jiao C, et al. Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis. Oncotarget. 2017;8(64):107577–107588.
   PubMedGoogle Scholar
• Sokol H, Leducq V, Aschard H, et al. Fungal microbiota dysbiosis in IBD. Gut. 2017;66(6):1039–1048.
   PubMed Web of Science ®Google Scholar
• Ott SJ, Kühbacher T, Musfeldt M, et al. Fungi and inflammatory bowel diseases: Alterations of composition and diversity. Scand J Gastroenterol. 2008;43(7):831–841.
   PubMed Web of Science ®Google Scholar
• Strati F, Di Paola M, Stefanini I, et al. Age and gender affect the composition of fungal population of the human gastrointestinal tract. Front Microbiol. 2016;7:1227.
   PubMed Web of Science ®Google Scholar
• Iliev ID, Leonardi I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat Rev Immunol. 2017;17(10):635–646.
   PubMed Web of Science ®Google Scholar
• Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489(7415):220–230.
   PubMed Web of Science ®Google Scholar
• Suhr MJ, Banjara N, Hallen-Adams HE. Sequence-based methods for detecting and evaluating the human gut mycobiome. Lett Appl Microbiol. 2016;62(3):209–215.
   PubMed Web of Science ®Google Scholar
• Dollive S, Peterfreund GL, Sherrill-Mix S, et al. A tool kit for quantifying eukaryotic rRNA gene sequences from human microbiome samples. Genome Biol. 2012;13(7):R60.
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Dollive S, Grunberg S, et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLOS One. 2013;8(6):e66019.
   PubMed Web of Science ®Google Scholar
• Miyoshi J, Sofia MA, Pierre JF. The evidence for fungus in Crohn's disease pathogenesis. Clin J Gastroenterol. 2018;11(6):449–456.
   PubMed Web of Science ®Google Scholar
• Liguori G, Lamas B, Richard ML, et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn's disease patients. ECCOJC. 2016;10(3):296–305.
   Web of Science ®Google Scholar
• Qiu X, Zhang F, Yang X, et al. Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis. Sci Rep. 2015;5:10416.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang C, Tang C, et al. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease. J Clin Gastroenterol. 2014;48(6):513–523.
   PubMed Web of Science ®Google Scholar
• Lam S, Zuo T, Ho M, et al. Review article: fungal alterations in inflammatory bowel diseases. Aliment Pharmacol Ther. 2019;50(11–12):1159–1171.
   PubMed Web of Science ®Google Scholar
• Limon JJ, Tang J, Li D, et al. Malassezia is associated with crohn's disease and exacerbates colitis in mouse models. Cell Host Microbe. 2019;25(3):377–388.e6.
   PubMed Web of Science ®Google Scholar
• Stamatiades GA, Ioannou P, Petrikkos G, et al. Fungal infections in patients with inflammatory bowel disease: a systematic review. Mycoses. 2018;61(6):366–376.
   PubMed Web of Science ®Google Scholar
• Schirbel A, Shouval DS, Hebecker B, et al. Intestinal epithelial cells and T cells differentially recognize and respond to Candida albicans yeast and hypha. Eur J Immunol. 2018;48(11):1826–1837.
   PubMed Web of Science ®Google Scholar
• Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ. 1988;297(6656):1105–1106.
   PubMed Web of Science ®Google Scholar
• Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42(6):788–791.
   PubMed Web of Science ®Google Scholar
• Sutton CL, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut. 2000;46(1):58–63.
   PubMed Web of Science ®Google Scholar
• Walker LJ, Aldhous MC, Drummond HE, et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol. 2004;135(3):490–496.
   PubMed Web of Science ®Google Scholar
• Hoarau G, Mukherjee PK, Gower-Rousseau C, et al. Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn's disease. mBio. 2016;7(5):e01250-16.
   PubMed Web of Science ®Google Scholar
• Leonardi I, Li X, Semon A, et al. CX3CR1 mononuclear phagocytes control immunity to intestinal fungi. Science. 2018;359(6372):232–236.
   PubMed Web of Science ®Google Scholar
• Richard ML, Liguori G, Lamas B, et al. Mucosa-associated microbiota dysbiosis in colitis associated cancer. Gut Microbes. 2018;9(2):131–142.
   PubMed Web of Science ®Google Scholar
• Mukhopadhya I, Hansen R, Meharg C, et al. The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect. 2015;17(4):304–310.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Chen EZ, Baldassano RN, et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe. 2015;18(4):489–500.
   PubMed Web of Science ®Google Scholar
• Mouzan MIE, Korolev KS, Mofarreh MAA, et al. Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease. WJG. 2018;24(39):4510–4516.
   PubMed Web of Science ®Google Scholar
• Hager CL, Ghannoum MA. The mycobiome: role in health and disease, and as a potential probiotic target in gastrointestinal disease. Digest Liver Dis. 2017;49(11):1171–1176.
   Web of Science ®Google Scholar
• Yan P-G, Li J-N. Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease. Chin Med J. 2020;133(7):834–841.
   PubMed Web of Science ®Google Scholar
• Guan Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019;2019:7247238.
   PubMed Web of Science ®Google Scholar
• Drewniak A, Gazendam RP, Tool ATJ, et al. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood. 2013;121(13):2385–2392.
   PubMed Web of Science ®Google Scholar
• Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases. J Clin Invest. 2014;124(10):4190–4196.
   PubMed Web of Science ®Google Scholar
• Goodridge HS, Reyes CN, Becker CA, et al. Activation of the innate immune receptor dectin-1 upon formation of a ‘phagocytic synapse’. Nature. 2011;472(7344):471–475.
   PubMed Web of Science ®Google Scholar
• Wang T, Pan D, Zhou Z, et al. Dectin-3 deficiency promotes colitis development due to impaired antifungal innate immune responses in the gut. PLOS Pathog. 2016;12(6):e1005662.
   PubMed Web of Science ®Google Scholar
• Moltzau Anderson J, Lipinski S, Sommer F, et al. NOD2 influences trajectories of intestinal microbiota recovery after antibiotic perturbation. Cell Mol Gastroenterol Hepatol. 2020;10(2):365–389.
   PubMed Web of Science ®Google Scholar
• Wagener J, Malireddi RKS, Lenardon MD, et al. Fungal chitin dampens inflammation through IL-10 induction mediated by NOD2 and TLR9 activation. PLOS Pathog. 2014;10(4):e1004050.
   PubMed Web of Science ®Google Scholar
• Singel KL, Segal BH. NOX2-dependent regulation of inflammation. Clin Sci. 2016;130(7):479–490.
   PubMed Web of Science ®Google Scholar
• Hedjoudje A, Cheurfa C, Briquez C, et al. rs2476601 polymorphism in PTPN22 is associated with Crohn's disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls. Ann Gastroenterol. 2017;30(2):197–208.
   PubMed Web of Science ®Google Scholar
• Pérez de Diego R, Sánchez-Ramón S, López-Collazo E, et al. Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: molecular, immunologic, and clinical heterogeneity. J Allergy Clin Immunol. 2015;136(5):1139–1149.
   PubMed Web of Science ®Google Scholar
• Roth S, Ruland J. Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation. Trends Immunol. 2013;34(6):243–250.
   PubMed Web of Science ®Google Scholar
• Malik A, Sharma D, Malireddi RKS, et al. SYK-CARD9 signaling axis promotes gut fungi-mediated inflammasome activation to restrict colitis and colon cancer. Immunity. 2018;49(3):515–530.e5.
   PubMed Web of Science ®Google Scholar
• Glocker E-O, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009;361(18):1727–1735.
   PubMed Web of Science ®Google Scholar
• Sokol H, Conway KL, Zhang M, et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology. 2013;145(3):591–601.e3.
   PubMed Web of Science ®Google Scholar
• Lamas B, Richard ML, Leducq V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22(6):598–605.
   PubMed Web of Science ®Google Scholar
• Iliev ID, Funari VA, Taylor KD, et al. Interactions between commensal fungi and the C-type lectin receptor dectin-1 influence colitis. Science. 2012;336(6086):1314–1317.
   PubMed Web of Science ®Google Scholar
• Zhao X-Q, Zhu L-L, Chang Q, et al. C-type lectin receptor dectin-3 mediates trehalose 6,6′-dimycolate (TDM)-induced mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation. J Biol Chem. 2014;289(43):30052–30062.
   PubMed Web of Science ®Google Scholar
• Zhu L-L, Zhao X-Q, Jiang C, et al. C-type lectin receptors dectin-3 and dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity. 2013;39(2):324–334.
   PubMed Web of Science ®Google Scholar
• Terciolo C, Dapoigny M, Andre F. Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption. Clin Exp Gastroenterol. 2019;12:67–82.
   PubMed Web of Science ®Google Scholar
• Yu Y, Yang W, Li Y, et al. Enteroendocrine cells: sensing gut microbiota and regulating inflammatory bowel diseases. Inflamm Bowel Dis. 2020;26(1):11–20.
   PubMed Web of Science ®Google Scholar
• Chehoud C, Albenberg LG, Judge C, et al. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1948–1956.
   PubMed Web of Science ®Google Scholar
• Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445–1456.
   PubMed Web of Science ®Google Scholar
• Mohammad Jafari R, Shayesteh S, Ala M, et al. Dapsone ameliorates colitis through TLR4/NF-kB pathway in TNBS induced colitis model in rat. Arch Med Res. 2021;S0188-4409(21)00076-X.
   PubMed Web of Science ®Google Scholar
• Li J, Chen D, Yu B, et al. Fungi in gastrointestinal tracts of human and mice: from community to functions. Microb Ecol. 2018;75(4):821–829.
   PubMed Web of Science ®Google Scholar
• Caër C, Wick MJ. Human intestinal mononuclear phagocytes in health and inflammatory bowel disease. Front Immunol. 2020;11:410.
   PubMed Web of Science ®Google Scholar
• Leonardi I, Li X, Iliev ID. Macrophage interactions with fungi and bacteria in inflammatory bowel disease. Curr Opin Gastroenterol. 2018;34(6):392–397.
   PubMed Web of Science ®Google Scholar
• Di Paola M, Rizzetto L, Stefanini I, et al. Comparative immunophenotyping of Saccharomyces cerevisiae and Candida spp. strains from Crohn's disease patients and their interactions with the gut microbiome. J Transl Autoimmun. 2020;3:100036.
   PubMedGoogle Scholar
• Bouguen G, Chevaux J-B, Peyrin-Biroulet L. Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases. World J Gastroenterol. 2011;17(5):547–556.
   PubMed Web of Science ®Google Scholar
• De Luca A, Carvalho A, Cunha C, et al. IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis. PLOS Pathog. 2013;9(7):e1003486.
   PubMed Web of Science ®Google Scholar
• Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329–342.
   PubMed Web of Science ®Google Scholar
• Hedl M, Zheng S, Abraham C. The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways. J Immunol. 2014;192(12):5924–5932.
   PubMed Web of Science ®Google Scholar
• Pizarro TT, Cominelli F. Cytokine therapy for Crohn's disease: advances in translational research. Annu Rev Med. 2007;58:433–444.
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–434.
   PubMed Web of Science ®Google Scholar
• McGovern D, Powrie F. The IL23 axis plays a key role in the pathogenesis of IBD. Gut. 2007;56(10):1333–1336.
   PubMed Web of Science ®Google Scholar
• Netea MG, Brown GD, Kullberg BJ, et al. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol. 2008;6(1):67–78.
   PubMed Web of Science ®Google Scholar
• Zelante T, De Luca A, Bonifazi P, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol. 2007;37(10):2695–2706.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol. 2007;19(6):652–657.
   PubMed Web of Science ®Google Scholar
• Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010;238(1):247–262.
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Netea MG. T-cell subsets and antifungal host defenses. Curr Fungal Infect Rep. 2010;4(4):238–243.
   PubMedGoogle Scholar
• Barouti N, Mainetti C, Fontao L, et al. L-tryptophan as a novel potential pharmacological treatment for wound healing via aryl hydrocarbon receptor activation. Dermatology. 2015;230(4):332–339.
   PubMed Web of Science ®Google Scholar
• Di Meglio P, Duarte JH, Ahlfors H, et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity. 2014;40(6):989–1001.
   PubMed Web of Science ®Google Scholar
• Wheeler ML, Limon JJ, Underhill DM. Immunity to commensal fungi: detente and disease. Annu Rev Pathol. 2017;12:359–385.
   PubMed Web of Science ®Google Scholar
• Kadow S, Jux B, Zahner SP, et al. Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the murine epidermis. J Immunol. 2011;187(6):3104–3110.
   PubMed Web of Science ®Google Scholar
• Vlachos C, Schulte BM, Magiatis P, et al. Malassezia-derived indoles activate the aryl hydrocarbon receptor and inhibit toll-like receptor-induced maturation in monocyte-derived dendritic cells. Br J Dermatol. 2012;167(3):496–505.
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008;453(7191):106–109.
   PubMed Web of Science ®Google Scholar
• Duarte-Silva M, Afonso PC, de Souza PR, et al. Reappraisal of antibodies against Saccharomyces cerevisiae (ASCA) as persistent biomarkers in quiescent Crohn's disease. Autoimmunity. 2019;52(1):37–47.
   PubMed Web of Science ®Google Scholar
• Standaert-Vitse A, Jouault T, Vandewalle P, et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology. 2006;130(6):1764–1775.
   PubMed Web of Science ®Google Scholar
• Jawhara S, Thuru X, Standaert-Vitse A, et al. Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis. 2008;197(7):972–980.
   PubMed Web of Science ®Google Scholar
• Schaffer T, Müller S, Flogerzi B, et al. Anti-Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflamm Bowel Dis. 2007;13(11):1339–1346.
   PubMed Web of Science ®Google Scholar
• Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol. 2009;104(7):1745–1753.
   PubMed Web of Science ®Google Scholar
• Pérez T, Balcázar JL, Ruiz-Zarzuela I, et al. Host-microbiota interactions within the fish intestinal ecosystem. Mucosal Immunol. 2010;3(4):355–360.
   PubMed Web of Science ®Google Scholar
• Seow CH, Stempak JM, Xu W, et al. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Am J Gastroenterol. 2009;104(6):1426–1434.
   PubMed Web of Science ®Google Scholar
• Sovran B, Planchais J, Jegou S, et al. Enterobacteriaceae are essential for the modulation of colitis severity by fungi. Microbiome. 2018;6(1):152.
   PubMed Web of Science ®Google Scholar
• Castro DP, Seabra SH, Garcia ES, et al. Trypanosoma cruzi: ultrastructural studies of adhesion, lysis and biofilm formation by Serratia marcescens. Exp Parasitol. 2007;117(2):201–207.
   PubMed Web of Science ®Google Scholar
• Grishin A, Papillon S, Bell B, et al. The role of the intestinal microbiota in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg. 2013;22(2):69–75.
   PubMed Web of Science ®Google Scholar
• Bandara HMHN, Yau JYY, Watt RM, et al. Escherichia coli and its lipopolysaccharide modulate in vitro candida biofilm formation. J Med Microbiol. 2009;58(12):1623–1631.
   PubMed Web of Science ®Google Scholar
• Mendes A, Mores AU, Carvalho AP, et al. Candida albicans biofilms produce more secreted aspartyl protease than the planktonic cells. Biol Pharm Bull. 2007;30(9):1813–1815.
   PubMed Web of Science ®Google Scholar
• Chiaro TR, Soto R, Zac Stephens W, et al. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med. 2017;9(380):eaaf9044.
   PubMed Web of Science ®Google Scholar
• Huseyin CE, O'Toole PW, Cotter PD, et al. Forgotten fungi-the gut mycobiome in human health and disease. FEMS Microbiol Rev. 2017;41(4):479–511.
   PubMed Web of Science ®Google Scholar
• Albuquerque P, Casadevall A. Quorum sensing in fungi-a review. Med Mycol. 2012;50(4):337–345.
   PubMed Web of Science ®Google Scholar
• Schreiber D, Marx L, Felix S, et al. Anti-inflammatory effects of fungal metabolites in mouse intestine as revealed by in vitro models. Front Physiol. 2017;8:566.
   PubMed Web of Science ®Google Scholar
• Sivignon A, de Vallée A, Barnich N, et al. Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease. Inflamm Bowel Dis. 2015;21(2):276–286.
   PubMed Web of Science ®Google Scholar
• Jiang TT, Shao T-Y, Ang WXG, et al. Commensal fungi recapitulate the protective benefits of intestinal bacteria. Cell Host Microbe. 2017;22(6):809–816.e4.
   PubMed Web of Science ®Google Scholar
• Rizzetto L, Ifrim DC, Moretti S, et al. Fungal chitin induces trained immunity in human monocytes during cross-talk of the host with Saccharomyces cerevisiae. J Biol Chem. 2016;291(15):7961–7972.
   PubMed Web of Science ®Google Scholar
• Buentke E, Heffler LC, Wilson JL, et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J Invest Dermatol. 2002;119(4):850–857.
   PubMed Web of Science ®Google Scholar
• Selander C, Engblom C, Nilsson G, et al. TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J Immunol. 2009;182(7):4208–4216.
   PubMed Web of Science ®Google Scholar
• Suhr MJ. Characterization and investigation of fungi inhabiting the gastrointestinal tract of healthy and diseased humans. Dissertations, Theses, & Student Research in Food Science and Technology. 2015.
   Google Scholar
• Fieber JH, Atladóttir J, Solomon DG, et al. Disseminated enteroinvasive aspergillosis in a critically ill patient without severe immunocompromise. J Surg Case Rep. 2013;2013(11):rjt091.
   PubMedGoogle Scholar
• Marti Aguado D, Ballester MP, Bosca Watts MM. Invasive pulmonary aspergillosis in an immunocompromised patient with severe ulcerative colitis. Rev Esp Enfermed Digest. 2017;109(4):316–317.
   PubMed Web of Science ®Google Scholar
• Zwolinska-Wcislo M, Brzozowski T, Budak A, et al. Effect of candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol. 2009;60(1):107–118.
   PubMed Web of Science ®Google Scholar
• Recinella L, Chiavaroli A, Ronci M, et al. Multidirectional pharma-toxicological study on DC. ex meisn.: an IBD-focused investigation. Antioxidants. 2020;9(2):168.
   Web of Science ®Google Scholar
• Ferrante C, Recinella L, Ronci M, et al. Multiple pharmacognostic characterization on hemp commercial cultivars: focus on inflorescence water extract activity. Food Chem Toxicol. 2019;125:452–461.
   PubMed Web of Science ®Google Scholar
• Ferrante C, Recinella L, Ronci M, et al. Protective effects induced by alcoholic Phlomis fruticosa and Phlomis herba-venti extracts in isolated rat colon: focus on antioxidant, anti-inflammatory, and antimicrobial activities in vitro. Phytother Res. 2019;33(9):2387–2400.
   PubMed Web of Science ®Google Scholar
• Zengin G, Ferrante C, Orlando G, et al. Chemical profiling and pharmaco-toxicological activity of Origanum sipyleum extracts: exploring for novel sources for potential therapeutic agents. J Food Biochem. 2019;43(11):e13003.
   PubMed Web of Science ®Google Scholar
• Zengin G, Ferrante C, Gnapi DE, et al. Comprehensive approaches on the chemical constituents and pharmacological properties of flowers and leaves of American basil (Ocimum americanum L). Food Res Int. 2019;125:108610.
   PubMed Web of Science ®Google Scholar
• Dalmasso G, Cottrez F, Imbert V, et al. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology. 2006;131(6):1812–1825.
   PubMed Web of Science ®Google Scholar
• Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. J Cell Physiol. 2018;233(3):2091–2103.
   PubMed Web of Science ®Google Scholar
• Matijašić M, Meštrović T, Paljetak HČ, et al. Gut microbiota beyond bacteria-mycobiome, virome, archaeome, and eukaryotic parasites in IBD. Int J Mol Sci. 2020;21(8):2668.
   PubMed Web of Science ®Google Scholar
• Lim BO. Coriolus versicolor suppresses inflammatory bowel disease by inhibiting the expression of STAT1 and STAT6 associated with IFN-γ and IL-4 expression. Phytother Res. 2011;25(8):1257–1261.
   PubMed Web of Science ®Google Scholar
• Li M, Luo T, Huang Y, et al. Polysaccharide from Pycnoporus sanguineus ameliorates dextran sulfate sodium-induced colitis via helper T cells repertoire modulation and autophagy suppression. Phytother Res. 2020;34(10):2649–2664.
   PubMed Web of Science ®Google Scholar
• Leonardi I, Paramsothy S, Doron I, et al. Fungal trans-kingdom dynamics linked to responsiveness to fecal microbiota transplantation (FMT) therapy in ulcerative colitis. Cell Host Microbe. 2020;27(5):823–829.e3.
   PubMed Web of Science ®Google Scholar
• Kostovcikova K, Coufal S, Galanova N, et al. Diet rich in animal protein promotes pro-inflammatory macrophage response and exacerbates colitis in mice. Front Immunol. 2019;10:919.
   PubMed Web of Science ®Google Scholar
• Nagatani K, Wang S, Llado V, et al. Chitin microparticles for the control of intestinal inflammation. Inflamm Bowel Dis. 2012;18(9):1698–1710.
   PubMed Web of Science ®Google Scholar
• Azuma K, Osaki T, Ifuku S, et al. α-Chitin nanofibrils improve inflammatory and fibrosis responses in inflammatory bowel disease mice model. Carbohydr Polym. 2012;90(1):197–200.
   PubMed Web of Science ®Google Scholar
• Louis P, Mercer B, Cirone AM, et al. Dietary chitin particles called mimetic fungi ameliorate colitis in toll-like receptor 2/CD14- and sex-dependent manners. Infect Immun. 2019;87(5):e00006-19.
   PubMed Web of Science ®Google Scholar